Call Options Transactions Made in Q1 2024 in Arrowhead Pharmaceuticals, Inc. (ARWR)
This table provides information about the institutional ownership of Arrowhead Pharmaceuticals, Inc. (ARWR) during Q1 2024. The information is specifically focused on institutions that hold call options of ARROWHEAD PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 13, 2024
Q1 2024
|
Artal Group S.A.
Luxembourg, N4 |
BUY
|
CALL |
400K+ 200.0% |
$10.9M - $15.8M
|
600K
$12.6M
|
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
BUY
|
CALL |
23K+ 76.67% |
$626K - $908K
|
53K
$1.12M
|
|
|
May 15, 2024
Q1 2024
|
Centiva Capital, LP
New York, NY |
BUY
|
CALL |
15KNew |
$408K - $592K
|
15K
$316K
|
|
|
May 13, 2024
Q1 2024
|
Jefferies Financial Group Inc.
New York, NY |
BUY
|
CALL |
13KNew |
$354K - $513K
|
13K
$274K
|
|
|
May 10, 2024
Q1 2024
|
Citigroup Inc
|
BUY
|
CALL |
7.1K+ 39.89% |
$193K - $280K
|
24.9K
$524K
|
|
|
May 15, 2024
Q1 2024
|
Torno Capital, LLC
Cohasset, MA |
SELL
|
CALL |
-6.9K- 92.0% |
$188K - $272K
|
600
$12.6K
|
|
|
May 15, 2024
Q1 2024
|
Wolverine Trading, LLC
Chicago, IL |
SELL
|
CALL |
-15.2K- 48.41% |
$414K - $600K
|
16.2K
$341K
|
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-56.9K- 73.32% |
$1.55M - $2.25M
|
20.7K
$436K
|
|
|
May 07, 2024
Q1 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-68.1K- 29.99% |
$1.85M - $2.69M
|
159K
$3.35M
|